WO2007086457A1 - 乾式直打速崩壊性錠剤 - Google Patents

乾式直打速崩壊性錠剤 Download PDF

Info

Publication number
WO2007086457A1
WO2007086457A1 PCT/JP2007/051156 JP2007051156W WO2007086457A1 WO 2007086457 A1 WO2007086457 A1 WO 2007086457A1 JP 2007051156 W JP2007051156 W JP 2007051156W WO 2007086457 A1 WO2007086457 A1 WO 2007086457A1
Authority
WO
WIPO (PCT)
Prior art keywords
sodium
disintegrating tablet
dry
acid
tablet
Prior art date
Application number
PCT/JP2007/051156
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
Misa Tateda
Satoshi Sakuma
Itsumi Enomoto
Original Assignee
Toa Pharmaceuticals Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toa Pharmaceuticals Co., Ltd. filed Critical Toa Pharmaceuticals Co., Ltd.
Priority to KR1020087019484A priority Critical patent/KR101386022B1/ko
Priority to CN200780003393XA priority patent/CN101374503B/zh
Publication of WO2007086457A1 publication Critical patent/WO2007086457A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/JP2007/051156 2006-01-26 2007-01-25 乾式直打速崩壊性錠剤 WO2007086457A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020087019484A KR101386022B1 (ko) 2006-01-26 2007-01-25 건식 직타 속붕괴성 정제
CN200780003393XA CN101374503B (zh) 2006-01-26 2007-01-25 干式直压速崩性片剂

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006017401A JP4965130B2 (ja) 2006-01-26 2006-01-26 乾式直打速崩壊性錠剤
JP2006-017401 2006-01-26

Publications (1)

Publication Number Publication Date
WO2007086457A1 true WO2007086457A1 (ja) 2007-08-02

Family

ID=38309245

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/051156 WO2007086457A1 (ja) 2006-01-26 2007-01-25 乾式直打速崩壊性錠剤

Country Status (4)

Country Link
JP (1) JP4965130B2 (ko)
KR (1) KR101386022B1 (ko)
CN (1) CN101374503B (ko)
WO (1) WO2007086457A1 (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020262618A1 (en) * 2019-06-28 2020-12-30 Ssp Co., Ltd. Meloxicam-containing granulated product
CN115093859A (zh) * 2022-05-05 2022-09-23 朱贵远 一种聚丙烯酸钠防溅制剂及其制备方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
KR101592620B1 (ko) 2008-10-08 2016-02-05 도쿠리츠교세이호진 노교간쿄기쥬츠겐큐쇼 유해 물질 흡착 성형체
US9795568B2 (en) * 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
JP5810819B2 (ja) * 2011-10-14 2015-11-11 ライオン株式会社 積層錠
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
JP6266891B2 (ja) * 2013-03-29 2018-01-24 株式会社ロッテ 口腔内洗浄用組成物
CN103417512B (zh) * 2013-08-20 2015-08-12 吉林显锋科技制药有限公司 一种阿莫西林胶囊剂及其制备方法
WO2018010543A1 (zh) * 2016-07-11 2018-01-18 武汉朗来科技发展有限公司 一种用于口服固体制剂的复合崩解剂体系及含有该复合崩解剂体系的口服固体制剂
CN107970219A (zh) * 2017-12-27 2018-05-01 佛山市南海东方澳龙制药有限公司 宠物用美洛昔康片及其制备方法和应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000054752A1 (fr) * 1999-03-15 2000-09-21 Kaken Pharmaceutical Co., Ltd. Comprimes a delitement rapide et procede de fabrication
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2001513563A (ja) * 1997-08-27 2001-09-04 ヘキサル アーゲー 溶解性および生物学的利用能の改良されたメロキシカムの医薬組成物
WO2004071490A1 (en) * 2003-02-12 2004-08-26 R & P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
JP2004525975A (ja) * 2001-04-21 2004-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 素早く崩壊するメロキシカム錠剤
WO2005123040A1 (ja) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. 口腔内速崩壊錠

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1014984A1 (en) * 1997-08-27 2000-07-05 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
JP3435664B2 (ja) * 1999-12-08 2003-08-11 ヤンセンファーマ株式会社 口腔内速崩壊型錠剤及びその製造方法
JP2005306770A (ja) * 2004-04-21 2005-11-04 Toa Eiyo Ltd 口腔内速崩壊型製剤及びその製造方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513563A (ja) * 1997-08-27 2001-09-04 ヘキサル アーゲー 溶解性および生物学的利用能の改良されたメロキシカムの医薬組成物
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
WO2000054752A1 (fr) * 1999-03-15 2000-09-21 Kaken Pharmaceutical Co., Ltd. Comprimes a delitement rapide et procede de fabrication
JP2004525975A (ja) * 2001-04-21 2004-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 素早く崩壊するメロキシカム錠剤
WO2004071490A1 (en) * 2003-02-12 2004-08-26 R & P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
WO2005123040A1 (ja) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. 口腔内速崩壊錠

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020262618A1 (en) * 2019-06-28 2020-12-30 Ssp Co., Ltd. Meloxicam-containing granulated product
JP2021008412A (ja) * 2019-06-28 2021-01-28 エスエス製薬株式会社 メロキシカム含有造粒物
JP7348703B2 (ja) 2019-06-28 2023-09-21 エスエス製薬株式会社 メロキシカム含有造粒物
CN115093859A (zh) * 2022-05-05 2022-09-23 朱贵远 一种聚丙烯酸钠防溅制剂及其制备方法
CN115093859B (zh) * 2022-05-05 2024-03-01 朱贵远 一种聚丙烯酸钠防溅制剂及其制备方法

Also Published As

Publication number Publication date
KR20080108227A (ko) 2008-12-12
KR101386022B1 (ko) 2014-04-16
JP4965130B2 (ja) 2012-07-04
CN101374503A (zh) 2009-02-25
CN101374503B (zh) 2012-09-05
JP2007197357A (ja) 2007-08-09

Similar Documents

Publication Publication Date Title
JP4965130B2 (ja) 乾式直打速崩壊性錠剤
TWI376243B (en) Oral disintegrating tablet
JP5296456B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
WO2004017947A1 (en) Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets
KR20040058189A (ko) 관능상 허용가능한 경구내 붕해 조성물
JP6919119B2 (ja) ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
JP5870690B2 (ja) 口腔内崩壊錠及びその製造方法
JP2017141299A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP5974469B2 (ja) 錠剤の製造方法
JP2010270110A (ja) ネオテームを含有する経口製剤
JP2016053079A (ja) 錠剤及びその製造方法
JP2003176242A (ja) 速崩壊性圧縮成型物及びその製造法
JP3899522B2 (ja) 苦味が低減されたプランルカスト水和物を含有する製剤
JP2010241760A (ja) 不快な味の軽減された口腔内速崩壊錠及びその製造方法
TW201315462A (zh) 異丁苯丙酸可嚼錠
TWI468189B (zh) Oral internal disintegrating tablet and its manufacturing method
JPWO2010119851A1 (ja) 口腔内崩壊錠
JP5530716B2 (ja) 生薬含有錠剤、生薬含有錠剤用の生薬担持粒子の製造方法
JP7250305B2 (ja) メマンチン又はその薬物学的に許容される塩を含む医薬組成物及びその製造方法
JP6151413B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2015110663A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP5714652B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP7023186B2 (ja) 認知症治療薬を含有する口腔内崩壊性錠剤
JP3637968B1 (ja) 胃内崩壊性錠剤
US20240091367A1 (en) Orally disintegrating palatable formulations of drotaverine and method of preparation thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 200780003393.X

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1020087019484

Country of ref document: KR

122 Ep: pct application non-entry in european phase

Ref document number: 07707403

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)